US Patent 11834505 PD-L1-specific antibodies and methods of using the same
Patent 11834505 was granted and assigned to Checkpoint Therapeutics on December, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11834505 PD-L1-specific antibodies and methods of using the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
